Orchid Pharma Limited

Orchid Pharma Limited

Performance

Today's Low Today's High
1,618.65 1,617.35
1,685.00 1684.90
52 Week Low 52 Week High
556.85 (07-Dec-2023) 556.60 (07-Dec-2023)
1,685.00 (29-Nov-2024) 1,684.90 (29-Nov-2024)

Open
1,633.05 1,646.00
Previous Close
1,623.85 1,626.00
Volume
1.27
Total Traded value
20.93 (₹ Lakhs)
Upper circuit
1,948.60 908.90
Lower circuit
1,299.10 606.00

Market Depth

Buy Order Quantity Sell Order Quantity
30
0

Bid PriceQuantity
1,676.4530.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:30
Ask PriceQuantity
0.000.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:--

Fundamentals

Market Cap: ₹85.21 Cr
PE Ratio (TTM): 69.62
PB Ratio: 6.77
Industry P/E:69.87
Debt to Equity:-
ROE:9.72
EPS (TTM):23.36
Book Value:227.38
Face Value: 10.00

Financials

Sep, 2023Jun, 2023Mar, 2023Dec, 2022Sep, 2022
Revenue198.76 Cr182.92 Cr209.90 Cr159.76 Cr165.25 Cr
Profit20.24 Cr10.78 Cr64.87 Cr6.73 Cr-3.32 Cr
Expense186.70 Cr174.03 Cr184.91 Cr161.96 Cr174.41 Cr
Comprehensive income19.01 Cr10.72 Cr65.79 Cr6.36 Cr-3.69 Cr
EPS4.405.2815.891.65-0.81
Orchid Pharma Limited, a pharmaceutical company based in Chennai, India, specializes in the development, manufacturing, and marketing of various pharmaceutical products. With a diverse product portfolio, the company offers active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals. Its range of active pharmaceutical ingredients includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. Orchid Pharma Limited has a strong presence in multiple therapeutic segments such as anti-infectives, anti-inflammatory, central nervous system, cardiovascular, nutraceuticals, and other oral and sterile products. The company also provides new drug discovery systems and pharmaceutical research and development services. With a global reach, Orchid Pharma Limited exports its products to approximately 40 countries worldwide. Additionally, the company offers liaising support to customers in regulatory affairs, pharma covigilance, testing and release, retention of samples, service providers, and business development. Formerly known as Orchid Chemicals & Pharmaceuticals Limited, the company changed its name to Orchid Pharma Limited in October 2015. Established in 1992, Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.
Company nameListing dateIndustry NSE symbol BSE symbol
Orchid Pharma Limited Nov, 2020 Dec, 1993 Pharmaceuticals Pharmaceuticals ORCHPHARMA ORCHPHARMA

Shareholding pattern

Sep, 2023 Jun, 2023 Jun, 2023 Mar, 2023 Dec, 2022

  • Promoters 
    72.40%
    Public 
    27.60%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    72.40%
    Public 
    27.60%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    72.40%
    Public 
    27.60%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    89.96%
    Public 
    10.04%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    89.96%
    Public 
    10.04%
    Shares held by Employee Trusts 
    0.00%

Orchid Pharma Limited FAQ's

What is the range of today's stock performance for Orchid Pharma Limited?

Today's stock performance witnessed a fluctuation from a minimum of 1,618.65 on the NSE (National Stock Exchange) to a maximum of 1,685.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,617.35 to a high of 1,684.90.

What are the 52-week low and high values for Orchid Pharma Limited?

The stock's performance over the past 52 weeks reveals a low of 556.85 (occurred on 07-Dec-2023) and a high of 1,685.00 (achieved on 29-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 556.60 (on 07-Dec-2023), and the 52-week high is 1,684.90 (on 29-Nov-2024).

What was the opening and previous closing prices for Orchid Pharma Limited?

The stock's performance over the past 52 weeks reveals a low of 556.85 (occurred on 07-Dec-2023) and a high of 1,685.00 (achieved on 29-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 556.60 (on 07-Dec-2023), and the 52-week high is 1,684.90 (on 29-Nov-2024).

What is the total volume and traded value for Orchid Pharma Limited for the day?

The total volume is 1, and the total traded value is 20.93 (₹ Lakhs).

What are the upper and lower circuit limits for Orchid Pharma Limited?

The upper circuit limit is 1,948.60, and the lower circuit limit is 1,299.10.

What is the market cap and PE ratio for Orchid Pharma Limited?

The market cap is ₹85.21 Cr, and the PE ratio (TTM) is 69.87.

What is the PB ratio, industry P/E, and debt to equity ratio for Orchid Pharma Limited?

The PB ratio is 7.39, industry P/E is 69.87 .

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Orchid Pharma Limited?

ROE is 9.72, EPS is 23.36, book value is 227.38

What are the revenue and profit figures for the latest quarter and previous quarters for Orchid Pharma Limited?

In Sep 2023, Revenue is ₹1987553000.00, and Profit is ₹202417000.00. In Jun 2023, Revenue is ₹1829198000.00, and Profit is ₹107751000.00.

When was Orchid Pharma Limited listed, and what industry does it belong to?

The company, Orchid Pharma Limited, was listed in Nov 2020 and belongs to the Pharmaceuticals industry. Its NSE symbol is ORCHPHARMA.

What is the current shareholding pattern of the Orchid Pharma Limited?

As of latest available update, promoters hold 72.40%, the public holds 27.60%, and Employee Trusts holds 0.00.

The Indian Community

Public Community

Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.

Members
25
online
209
Threads
81
Settings
Back
Top